日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Incretins and MASLD: at the Crossroads of Endocrine and Hepatic Disorders

肠促胰素与MASLD:内分泌与肝脏疾病的交汇点

Farrugia, Marwin A; Pini, Enzo; Tran, Albert; Chevalier, Nicolas; Anty, Rodolphe; Gual, Philippe

Impact of Mlkl or Ripk3 deletion on age-associated liver inflammation, metabolic health, and lifespan.

Mlkl 或 Ripk3 缺失对年龄相关性肝脏炎症、代谢健康和寿命的影响

Mohammed Sabira, Ohene-Marfo Phoebe, Jiang Chao, Peng Zongkai, Thadathil Nidheesh, Tran Albert, Nicklas Evan, Bhaskaran Shylesh, Wang Dawei, Selvarani Ramasamy, Singh Amit, Yang Zhibo, Ahsan Nagib, Deepa Sathyaseelan S

Profiling of the tumor-associated microbiome in patients with hepatocellular carcinoma

肝细胞癌患者肿瘤相关微生物组的分析

Schulz, Christian; Vilchez-Vargas, Ramiro; Öcal, Elif; Koch, Nadine; Puhr-Westerheide, Daniel; Burnell, Lu Fornés; Hirner-Eppeneder, Heidrun; Benckert, Julia; Pech, Maciej; Reimer, Peter; Verslype, Chris; Kuhl, Christiane; Tran, Albert; Ricke, Jens; Malfertheiner, Peter; Alunni-Fabbroni, Marianna

A Non-canonical Role for Hepatocyte MLKL in Promoting Mitochondrial Dysfunction and Senescence in the Aging Liver

肝细胞MLKL在促进衰老肝脏线粒体功能障碍和衰老中的非经典作用

Mohammed, Sabira; Jiang, Chao; Pennington, Travis; Bhaskaran, Shylesh; Ohene-Marfo, Phoebe; Georgescu, Constantin; Pitts, Kamille; Tran, Albert; Peng, Zongkai; Singh, Amit; Yang, Zhibo; Li, Tiangang; Hannafon, Bethany; Houchen, Courtney; Wren, Jonathan D; Galvan, Veronica; Ahsan, Nagib; Kinter, Michael; Lewis, Tommy L; Deepa, Sathyaseelan S

Hepatocyte MLKL Drives Obesity-Driven Hepatocellular Carcinoma Progression via Mitochondrial Dysfunction Independent of Necroptosis in MASLD

在MASLD中,肝细胞MLKL通过线粒体功能障碍驱动肥胖相关的肝细胞癌进展,且该过程独立于坏死性凋亡。

Ohene-Marfo, Phoebe; Mohammed, Sabira; Jiang, Chao; Bhaskaran, Shylesh; Georgescu, Constantin; John, Megan; Pham, Kevin; Tran, Albert; Rao, Chinthalapally V; Gyu Oh, Tae; Kinter, Michael; Freeman, Willard M; Houchen, Courtney; Wren, Jonathan D; Deepa, Sathyaseelan S

Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial

Tislelizumab治疗既往接受过治疗的晚期肝细胞癌患者(RATIONALE-208):一项多中心、非随机、开放标签的II期试验

Ren, Zhenggang; Ducreux, Michel; Abou-Alfa, Ghassan K; Merle, Philippe; Fang, Weijia; Edeline, Julien; Li, Zhiwei; Wu, Lihua; Assenat, Eric; Hu, Sheng; Rimassa, Lorenza; Zhang, Tao; Blanc, Jean-Frédéric; Pan, Hongming; Ross, Paul; Yen, Chia-Jui; Tran, Albert; Shao, Guoliang; Bouattour, Mohamed; Chen, Yajin; Meyer, Tim; Hou, Jinlin; Tougeron, David; Bai, Yuxian; Hou, Ming-Mo; Meng, Zhiqiang; Wu, John; Li, Vincent; Chica-Duque, Sandra; Cheng, Ann-Lii

Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial

在 II 期 SORAMIC 试验中,局部消融治疗后索拉非尼辅助治疗对肝细胞癌的影响

Seidensticker, Max; Öcal, Osman; Schütte, Kerstin; Malfertheiner, Peter; Berg, Thomas; Loewe, Christian; Klümpen, Heinz Josef; van Delden, Otto; Ümütlü, Muzaffer Reha; Ben Khaled, Najib; de Toni, Enrico Narciso; Seidensticker, Ricarda; Aghdassi, Ali; Tran, Albert; Bronowicki, Jean-Pierre; Peynircioglu, Bora; Sangro, Bruno; Pech, Maciej; Ricke, Jens

Impaired Function of Solute Carrier Family 19 Leads to Low Folate Levels and Lipid Droplet Accumulation in Hepatocytes

溶质载体家族19功能受损导致肝细胞叶酸水平降低和脂滴积累

Cano, Ainara; Vazquez-Chantada, Mercedes; Conde-Vancells, Javier; Gonzalez-Lahera, Aintzane; Mosen-Ansorena, David; Blanco, Francisco J; Clément, Karine; Aron-Wisnewsky, Judith; Tran, Albert; Gual, Philippe; García-Monzón, Carmelo; Caballería, Joan; Castro, Azucena; Martínez-Chantar, María Luz; Mato, José M; Zhu, Huiping; Finnell, Richard H; Aransay, Ana M

Mid-Infrared Spectroscopy as a New Tool for Ruling Out Spontaneous Bacterial Peritonitis: A Proof-of-Concept Study

中红外光谱作为排除自发性细菌性腹膜炎的新工具:概念验证研究

Farrugia, Marwin A; Le Corvec, Maëna; Renou, Christophe; Nousbaum, Jean-Baptiste; Ouizeman, Dann J; Sire, Olivier; Loréal, Olivier; Tariel, Hugues; Bernard, Jérôme; Piche, Thierry; Tran, Albert; Ait-Oufella, Hafid; Landraud, Luce; Gual, Philippe; Anty, Rodolphe; The Cytokine Ascites Group

Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma

基于血浆生物标志物的晚期肝细胞癌3期CELESTIAL试验结果

Rimassa, Lorenza; Kelley, Robin Kate; Meyer, Tim; Ryoo, Baek-Yeol; Merle, Philippe; Park, Joong-Won; Blanc, Jean-Frederic; Lim, Ho Yeong; Tran, Albert; Chan, Yi-Wah; McAdam, Paul; Wang, Evelyn; Cheng, Ann-Lii; El-Khoueiry, Anthony B; Abou-Alfa, Ghassan K